Tegio is one of the key medications used in the treatment of stomach cancer, and its course of treatment needs to be tailored to different conditions, patients, and treatment regimens. When using Tegio in combination, a treatment regimen of 14 consecutive days of dosing and 7 days of withdrawal is used. For patients with early gastric cancer, it is recommended to stop the drug after 4-6 courses of treatment. For patients with intermediate and advanced stages, and patients with high risk of recurrence and metastasis, it is recommended to take 6-8 courses of treatment before stopping the drug. Combination therapy is not suitable for some patients. When using Tegio as a single agent for the treatment of tumors, a regimen of 14 consecutive days of use with 7 days of discontinuation may be used. A treatment regimen of 21 consecutive days of use and 14 days of discontinuation may also be used. Depending on the situation, it is recommended that patients with early gastric cancer take 4-6 courses of treatment and then stop the application. For patients with advanced gastric cancer, it is recommended to stop the drug after 6-8 courses of treatment according to the progress of the disease and the physical condition of different patients.